Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02835846 · ClinicalTrials.gov registry record · Phase 4
Investigation of the Effect of the Female Urinary Microbiome on Incontinence
A Phase 4 study, sponsored by Loyola University.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT02835846 is a Phase 4 study that has completed, run by Loyola University. The registered enrollment target is 35 participants.
The verdict
NCT02835846, a Phase 4 study, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
This purpose of this study is to understand the types of bacteria that are in the bladder and vagina in patients with overactive bladder (OAB) symptoms and understand if the types of bacteria change when with the use of estrogen in the vagina. The investigators are also trying to understand how estrogen influences the body's ability to make substances called peptides that can kill bacteria.
Interventions
- DRUG Estrogen Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02835846
The ClinicalTrials.gov registry entry for NCT02835846 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Estrogen Cream is the first listed.
NCT02835846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02835846 about?
NCT02835846 is a clinical study titled "Investigation of the Effect of the Female Urinary Microbiome on Incontinence". This purpose of this study is to understand the types of bacteria that are in the bladder and vagina in patients with overactive bladder (OAB) symptoms and understand if the types of bacteria change when with the use of estrogen in the vagina. The investigators are also trying to understand how estr...
What is the current status of trial NCT02835846?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2016-09. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02835846?
The interventions under investigation include: Estrogen Cream (DRUG).
Who is sponsoring clinical trial NCT02835846?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.